Lithium remains one of the most strategically important commodities for the global shift to electrification, clean energy, and energy storage. Demand for lithium is only rising, as supply continues to dwindle thanks to lower mine activity. In...
Dell (DELL) is quietly emerging as a major beneficiary of the AI infrastructure boom, too. Analysts at Barclays recently upgraded Dell to an overweight rating, citing growing confidence in the company’s positioning within the AI server market....
At record highs, gold could soon test $5,000. All as escalating tensions in Iran, mounting political pressure on the U.S. Federal Reserve, economic issues, and aggressive buying by global central banks boost demand. According to analysts at HSBC, rising...
by Ian Cooper Artificial intelligence hasn’t just fueled upside in tech stocks. It’s also fueling massive upside in energy stocks, most recently nuclear energy. As noted by Reuters, “some power companies projecting electricity sales growth several times higher than...
We’ve been pounding the table over obesity drug stocks for quite some time, we said on December 10. Look at Structure Therapeutics (GPCR). The first time we highlighted an opportunity in the stock, it traded at around $22 in late June. Today, it’s up to $78.50....
Artificial intelligence is fueling massive upside in energy stocks, most recently nuclear energy. Just last week, Meta unveiled agreements to secure about 6.6 GW of nuclear power by 2035 for its data centers. One of those deals was with Vistra Energy (SYM: VST),...
After dropping from about $413 to a recent low of $322.48, Broadcom is finding support from analysts at Bernstein. The firm just reiterated an "outperform" rating on the stock, thanks to its AI dominance. The firm also has a price target of $475 a share. Analysts at...
With global tensions mounting, defense stocks are expected to surge even higher. Earlier this week, defense stocks pulled back after President Trump said he would not allow dividends or buybacks for defense companies until arms production speeds up....
Palantir looks interesting for two reasons. One, it's slowly pivoting from overextensions on RSI, Williams' %R, and Full Stochastics. Two, it's gaining momentum on the Venezuela story. Venezuela and other troubling geopolitical issues are being met with...
by Ian Cooper With flu season nearing, it’s time to get flu shots and try your best to avoid germs. As anyone with a respiratory system will tell you, flu season isn’t fun. However, as any investor holding pharmacy and flu-related, coughing-sniffling remedy stocks...